Biosimilars - Impact for Patients | Aplastic Anemia & MDS International Foundation

Biosimilars - Impact for Patients

Managing Your Treatment
Presentation Date: 
Wednesday, November 13, 2019

In this webinar, Cate Lockhart - Executive Director at Biologics and Biosimilars Collective Intelligence Consortium, helps patients and families understand the difference between biologic and biosimilar medications. She discusses the approval process for FDA approval and how biosimiliar medications will impact the future of treating patients.